CHICAGO (AP) — Patients aren’t the only ones disappointed by delays in the Illinois medical marijuana program. A newly released report says investors are watching their hopes for financial returns fade, at least for this year.

A market research group tells investors to expect the 2015 Illinois market to be worth $5.7 million because of delays. The report from ArcView Market Research sees the market expanding to $36 million in 2016 as the program gets off the ground.

Company CEO Troy Dayton says Illinois Gov. Bruce Rauner’s plan to conduct a legal review of the program and former Gov. Pat Quinn’s failure to award business licenses before leaving office affect the numbers.

Peter Schweda of Downers Grove is a partner in an Illinois cultivation center business. He says investors are getting cold feet.

 

Copyright 2015 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.